The study found that semaglutide, sold under brand names Ozempic and Wegovy reduced the hospitalization risk by 22% in alcoholic patients. Ozempic had earlier been shown to mitigate joint pain.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Five years after he created LSD in a lab on this day in 1938, Albert Hofmann accidentally underwent the first acid trip in ...

Liquid IV and other electrolyte powders can help you hydrate — but is it possible to overdo it? Here's what experts want you ...

In today’s fast-paced world, maintaining optimal cognitive function is more important than ever. Whether you’re a student ...

The FDA's REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The U.S. Food and Drug Administration (FDA) has implemented new rules for TV drug ads to make them clearer and more direct in ...

The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...